![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](bi2233contents.gif)
Acta Cryst. (2007). E63, m2445 [ doi:10.1107/S1600536807042122 ]
2N,N')iron(II)]-
-5-carboxy-4-carboxylatoimidazol-1-ido-
4N3,O4:N1,O5]Abstract: The title compound, [Fe(C5H2N2O4)(C10H8N2)]n, was prepared by hydrothermal synthesis. The structure contains two crystallographically independent monomer units which exhibit similar geometry. The coordination environment of the FeII atom is octahedral, comprising two O atoms and four N atoms. Each FeII atom is chelated by one 2,2'-bipyridine ligand, and is linked to two neighbouring FeII atoms through bridging 5-carboxy-4-carboxylatoimidazol-1-ide ligands, forming zigzag chains parallel to the b axis. Intramolecular O-H
O hydrogen bonds are formed between the carboxy and carboxylate groups of each 5-carboxy-4-carboxylatoimidazol-1-ide ligand.
Online 1 September 2007
Copyright © International Union of Crystallography
IUCr Webmaster